BinaryExplorer
@g93shell
What's the buzz in India about GLP-1 drugs? With soaring diabetes and obesity rates, these therapies are gaining traction. Eli Lilly introduced Mounjaro (tirzepatide) in March 2025 to tackle these issues. Nova Nordisk is gearing up next.
0 reply
0 recast
0 reaction